Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
257 USD | +0.32% |
|
+1.24% | +34.74% |
15/07 | Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing | MT |
03/07 | Jerome Powell did it again | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.74% | 32.4B | |
+26.60% | 46.56B | |
+44.81% | 41.67B | |
-0.43% | 41.16B | |
+20.98% | 28.18B | |
-6.35% | 28.1B | |
+49.51% | 14.52B | |
+47.01% | 13.74B | |
+1.31% | 12.17B | |
-5.83% | 11.14B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Transcript : Alnylam Pharmaceuticals, Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 through Jan-11-2018